<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="39015">Apolipoprotein</z:chebi> E genotyping was carried out in a stratified random sample of 52 patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, 48 patients with vascular or mixed <z:hpo ids='HP_0000726'>dementia</z:hpo>, and 49 nondemented controls in a population-based study of people aged 85 and older (the Vantaa 85+ Study) </plain></SENT>
<SENT sid="1" pm="."><plain>Our results indicate that the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E epsilon 4 allele is associated with approximately a twofold increase in clinically diagnosed <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> in this very old general population aged 85+ </plain></SENT>
<SENT sid="2" pm="."><plain>When combined with previous studies, our data also suggest that the association is decreasing with age </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast, there appears to be no relation between <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E alleles and clinically diagnosed vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>